Cargando…
Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wiley Periodicals, Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084359/ https://www.ncbi.nlm.nih.gov/pubmed/28594116 http://dx.doi.org/10.1111/jns.12204 |
| _version_ | 1783346162691997696 |
|---|---|
| author | Merkies, Ingemar S. J. Lawo, John‐Philip Edelman, Jonathan M. De Bleecker, Jan L. Sommer, Claudia Robberecht, Wim Saarela, Mika Kamienowski, Jerzy Stelmasiak, Zbigniew Mielke, Orell Tackenberg, Björn Léger, Jean‐Marc |
| author_facet | Merkies, Ingemar S. J. Lawo, John‐Philip Edelman, Jonathan M. De Bleecker, Jan L. Sommer, Claudia Robberecht, Wim Saarela, Mika Kamienowski, Jerzy Stelmasiak, Zbigniew Mielke, Orell Tackenberg, Björn Léger, Jean‐Marc |
| author_sort | Merkies, Ingemar S. J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6084359 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Wiley Periodicals, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-60843592018-08-16 Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial Merkies, Ingemar S. J. Lawo, John‐Philip Edelman, Jonathan M. De Bleecker, Jan L. Sommer, Claudia Robberecht, Wim Saarela, Mika Kamienowski, Jerzy Stelmasiak, Zbigniew Mielke, Orell Tackenberg, Björn Léger, Jean‐Marc J Peripher Nerv Syst Letter to the Editor Wiley Periodicals, Inc. 2017-06-08 2017-06 /pmc/articles/PMC6084359/ /pubmed/28594116 http://dx.doi.org/10.1111/jns.12204 Text en © 2017 The Authors. Journal of the Peripheral Nervous System published by Wiley Periodicals, Inc. on behalf of Peripheral Nerve Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Merkies, Ingemar S. J. Lawo, John‐Philip Edelman, Jonathan M. De Bleecker, Jan L. Sommer, Claudia Robberecht, Wim Saarela, Mika Kamienowski, Jerzy Stelmasiak, Zbigniew Mielke, Orell Tackenberg, Björn Léger, Jean‐Marc Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial |
| title | Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial |
| title_full | Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial |
| title_fullStr | Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial |
| title_full_unstemmed | Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial |
| title_short | Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial |
| title_sort | minimum clinically important difference analysis confirms the efficacy of igpro10 in cidp: the prima trial |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084359/ https://www.ncbi.nlm.nih.gov/pubmed/28594116 http://dx.doi.org/10.1111/jns.12204 |
| work_keys_str_mv | AT merkiesingemarsj minimumclinicallyimportantdifferenceanalysisconfirmstheefficacyofigpro10incidptheprimatrial AT lawojohnphilip minimumclinicallyimportantdifferenceanalysisconfirmstheefficacyofigpro10incidptheprimatrial AT edelmanjonathanm minimumclinicallyimportantdifferenceanalysisconfirmstheefficacyofigpro10incidptheprimatrial AT debleeckerjanl minimumclinicallyimportantdifferenceanalysisconfirmstheefficacyofigpro10incidptheprimatrial AT sommerclaudia minimumclinicallyimportantdifferenceanalysisconfirmstheefficacyofigpro10incidptheprimatrial AT robberechtwim minimumclinicallyimportantdifferenceanalysisconfirmstheefficacyofigpro10incidptheprimatrial AT saarelamika minimumclinicallyimportantdifferenceanalysisconfirmstheefficacyofigpro10incidptheprimatrial AT kamienowskijerzy minimumclinicallyimportantdifferenceanalysisconfirmstheefficacyofigpro10incidptheprimatrial AT stelmasiakzbigniew minimumclinicallyimportantdifferenceanalysisconfirmstheefficacyofigpro10incidptheprimatrial AT mielkeorell minimumclinicallyimportantdifferenceanalysisconfirmstheefficacyofigpro10incidptheprimatrial AT tackenbergbjorn minimumclinicallyimportantdifferenceanalysisconfirmstheefficacyofigpro10incidptheprimatrial AT legerjeanmarc minimumclinicallyimportantdifferenceanalysisconfirmstheefficacyofigpro10incidptheprimatrial AT minimumclinicallyimportantdifferenceanalysisconfirmstheefficacyofigpro10incidptheprimatrial |